Abstract | BACKGROUND: MATERIALS AND METHODS: RESULTS: The results of this study for the first time demonstrate a down-regulation of EG-VEGF expression in human pituitary adenoma as compared to normal adenohypophysis, suggesting an impaired function of the neoplastic cells in terms of hormone release in the blood stream, as a consequence of impaired tumor angiogenesis in the tumor. CONCLUSION: On the basis of our data showing a marked decrease in the expression of EG-VEGF in pituitary adenoma, with the exception of LH-secreting adenomas, we suggest that LH might be involved in the induction of EG-VEGF secretion.
|
Authors | Marius Raica, Mihail Coculescu, Anca Maria Cimpean, Domenico Ribatti |
Journal | Anticancer research
(Anticancer Res)
Vol. 30
Issue 10
Pg. 3981-6
(Oct 2010)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 21036711
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
- Human Growth Hormone
- Adrenocorticotropic Hormone
- Prolactin
- Luteinizing Hormone
- Follicle Stimulating Hormone
- Thyrotropin
|
Topics |
- Adenoma
(metabolism)
- Adrenocorticotropic Hormone
(biosynthesis)
- Down-Regulation
- Follicle Stimulating Hormone
(biosynthesis)
- Human Growth Hormone
(biosynthesis)
- Humans
- Immunohistochemistry
- Luteinizing Hormone
(biosynthesis)
- Pituitary Gland, Anterior
(metabolism)
- Pituitary Neoplasms
(metabolism)
- Prolactin
(biosynthesis)
- Thyrotropin
(biosynthesis)
- Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
(biosynthesis)
|